Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars
10th Anniversary

Skip Nav Destination

Current Issue

Volume 11,

Issue 3

1 March 2023

View This Issue

About the Journal

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. Read More About the Journal

Editors-in-Chief

Robert D. Schreiber
Philip D. Greenberg

View Full Editorial Board

Impact Factor

12.020

SUBMIT TO JOURNAL

Featured Articles

RESEARCH ARTICLE

P. gingivalis Infection Upregulates PD-L1 Expression on Dendritic Cells, Suppresses CD8⁺ T-cell Responses, and Aggravates Oral Cancer

Junling Ren, et al.

RESEARCH ARTICLE

Syntaphilin Regulates Neutrophil Migration in Cancer

Shuyu Fu, et al.

RESEARCH ARTICLE

PHD2 Constrains Antitumor CD8+ T-cell Activity

Charlotte Bisilliat Donnet, et al.

Trending - Altmetric

Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

Last mentioned on Tuesday March 21 2023

pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens

Last mentioned on Tuesday March 21 2023

Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment

Last mentioned on Tuesday March 21 2023

P. gingivalisInfection Upregulates PD-L1 Expression on Dendritic Cells, Suppresses CD8+ T-cell Responses, and Aggravates Oral Cancer

Last mentioned on Friday March 17 2023

Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade

Last mentioned on Tuesday March 21 2023

Latest
Most Read
Most Cited

Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer

Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells

Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade

Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression

Tweets by CIR_AACR

Issues
Online First
News

Twitter

Online ISSN 2326-6074
Print ISSN 2326-6066

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept